Market revenue in 2023 | USD 522.6 million |
Market revenue in 2030 | USD 1,056.9 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.99% in 2023. Horizon Databook has segmented the India regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Global life sciences companies commonly outsource biopharmaceutical services to India. Cost benefits, improved infrastructure facilities, and large pool of technical expertise are some of the major drivers for growth of the Regulatory affairs outsourcing market in this region.
Global biopharmaceutical companies outsource manufacturing of biopharmaceutical products for clinical trials or sales in emerging countries such as India. The outsourcing trend in manufacturing is expected to increase the demand for regulatory services in the region by biopharmaceutical companies, thereby providing an opportunity for regulatory service providers or CROs to explore the market.
Horizon Databook provides a detailed overview of country-level data and insights on the India regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into India regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account